{
  "title": "Talking With Novartis CEO Vas Narasimhan",
  "description": "Vas Narasimhan joined Novartis in 2005 and became CEO in 2018. He discusses new initiatives at Novartis, and the opportunities and challenges facing the pharmaceutical industry with Barron's senior managing editor Lauren R. Rublin and healthcare reporter Josh Nathan-Kazis.",
  "pubDate": "Thu, 16 Dec 2021 23:21:00 -0000",
  "itunes:episodeType": "full",
  "itunes:author": "Barron's Live",
  "itunes:subtitle": "",
  "itunes:summary": "Vas Narasimhan joined Novartis in 2005 and became CEO in 2018. He discusses new initiatives at Novartis, and the opportunities and challenges facing the pharmaceutical industry with Barron's senior managing editor Lauren R. Rublin and healthcare reporter Josh Nathan-Kazis.",
  "content:encoded": "Vas Narasimhan joined Novartis in 2005 and became CEO in 2018. He discusses new initiatives at Novartis, and the opportunities and challenges facing the pharmaceutical industry with Barron's senior managing editor Lauren R. Rublin and healthcare reporter Josh Nathan-Kazis.",
  "itunes:duration": 2344,
  "guid": "83a62314-5f4c-11ec-b5ad-7f587284286c",
  "enclosure": ""
}